|
|
|
Insider
Information: |
Zuerblis Kenneth J |
Relationship: |
Director |
City: |
Bridgewater |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
51,497 |
|
Indirect Shares
|
10,963 |
|
|
Direct
Value |
$808,062 |
|
|
Indirect Value
|
$129,692 |
|
|
Total
Shares |
62,460 |
|
|
Total
Value |
$937,755 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Enzon Pharmaceuticals Inc |
ENZN |
Executive V.P., Financ... |
2004-06-14 |
35,330 |
2004-06-14 |
0 |
Premium* |
|
Immunomedics Inc |
IMMU |
Director |
2011-12-07 |
9,167 |
2010-12-01 |
0 |
Premium* |
|
Savient Pharmaceuticals Inc |
SVNTQ |
EVP, Chief Financial O... |
2011-11-18 |
7,000 |
2011-09-14 |
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Director |
2020-06-10 |
0 |
2013-05-30 |
10,963 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
STML |
Stemline Therapeutics Inc |
Director |
|
2020-06-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(60,121) |
0 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2019-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
60,121 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2018-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,158 |
45,121 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2017-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,963 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2015-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
21,963 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2014-09-02 |
4 |
B |
$11.14 |
$11,143 |
D/D |
1,000 |
11,963 |
2.39 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2013-05-30 |
4 |
B |
$16.38 |
$14,742 |
I/I |
900 |
10,963 |
2.1 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2013-05-29 |
4 |
B |
$15.85 |
$33,300 |
I/I |
2,100 |
10,063 |
2.1 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2013-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,963 |
|
- |
|
IMMU |
Immunomedics Inc |
Director |
|
2011-12-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
9,167 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2011-11-18 |
4 |
B |
$2.35 |
$4,690 |
D/D |
2,000 |
7,000 |
2.66 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2011-09-15 |
4 |
B |
$4.05 |
$16,190 |
D/D |
4,000 |
5,000 |
2.74 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2011-09-14 |
4 |
B |
$3.97 |
$3,970 |
D/D |
1,000 |
1,000 |
2.66 |
- |
|
IMMU |
Immunomedics Inc |
Director |
|
2010-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
4,167 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Executive V.P., Finance, CFO |
|
2004-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
35,330 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|